Abstract
This study aims to describe the distribution of interstitial lung diseases (ILD) in the South of Spain. Methods: A prospective multicentre population-based registry was established in nine provinces in the south of Spain with a population of 6,848,243 during a 3-year period (1998–2000). The number of participant physicians was 36 among 29 public hospitals. The number of diagnoses recorded was 66, divided in eight categories and coded according to ICD-9. A consensus document was elaborated for the classification of diseases and their diagnostic criteria. The number of cases declared was analysed each 3 months and communicated to each one of the participants. Results: There were 744 cases of them registered with an annual incidence of 3.62 cases/100,000. 40.1% of diagnoses were biopsy confirmed. Men had a slightly higher incidence (4.18 cases/100,000/year) than women (3.07 cases/100,000/year). The most frequent diseases found were: idiopathic interstitial pneumonias (38.58%), ILD associated to systemic diseases (20.97%), and Sarcoidosis (11.69%). According to province distribution, most of the cases were grouped in an area between the provinces of Seville and Cordoba, which comprised more than 50% of cases. Conclusions: The study of the incidence of ILD depicts an intermediate situation from previous studies on the incidence and distribution of this group of diseases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
National Institutes on Health, Division of Lung Diseases, National Heart, Lung, and Blood Institute. Report of task force on epidemiology of respiratory diseases. Washington, DC: US Department of Health and Human Services, 1980. NIH Publication No. 81-2019.
Coultas DB, Zumwalt RE, Black WC, Sobonya R. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994; 150: 967–972.
Roelandt M, Demedts M, Callebaut W, et al. Epidemiology of interstitial lung disease (ILD) in Flanders: Registration by pneumologists in 1992–1994. Working group on ILD, VRGT (Vereniging voor Respiratoire Gezondheidszorg en Tuberculosebestrijding). Acta Clin Belg 1995; 50: 260–268.
Schweisfurth H. Report by the Scientific Working Group for Therapy of Lung Diseases: German Fibrosis Register with initial results. Pneumologie 1996; 50: 899–901.
Rizzato G, Bariffi F. Epidemiological survey on interstitial lung disease in Italy: Leopard-spot-like data and results. L'Internista 1999; 7: 20–24.
World Health Organization. International classification of disease. Manual of the international classification of diseases, injuries, and causes of death-clinical modification. Geneva: World Health Organization, 1979.
Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: Clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998; 157: 1301–1315.
American Thoracic Society and European Respiratory Society. Idiopathic pulmonary fibrosis: Diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 2000; 161: 646–664.
American Thoracic Society. Statement on sarcoidosis. Am J Respir Crit Care Med 1999; 160: 736–755.
Epler GR. Bronchiolitis obliterans organizing pneumonia: Definition and clinical features. Chest 1992; 102(Suppl 1): 2S-6S.
Lapp NL, Parker JE. Coal workers' pneumoconiosis. Clin Chest Med 1992; 13: 243–252.
Graham WG. Silicosis. Clin Chest Med 1992; 13: 253–267.
Fink JN. Hypersensitivity pneumonitis. Clin Chest Med 1992; 13: 303–309.
Foucher P, Biour M, Blayac JP, et al. Drugs that may injure the respiratory system. Eur Respir J 1997; 10: 265–279.
Vassallo R, Ryu JH, Colby TV, Hartman TL, Andrew H. Medical progress: Pulmonary Langerhans'-Cell Histiocytosis. N Engl J Med 2000; 342: 1969–1978.
World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997; 277: 925–926.
Ley orgánica 5/1992, de 29 de Octubre, de regulación del tratamiento automatizado de los datos de carácter personal. BOE Nº 262: 37.037–37.045 (31 de Octubre de 1992).
Rothman KG. Measuring disease occurrence and causal effects. In: Rothman KG (ed), Epidemiology: An introduction. New York: Oxford University Press, 2002: 24–56.
Crystal RG, Gadek JE, Ferrans VJ, Fulmer JD, Line BR, Hunninghake GW. Interstitial lung disease: Current concepts of pathogenesis, staging and therapy. Am J Med 1981; 70: 542–568.
Demedts M, Wells AU, Antó JM, et al. Interstitial lung diseases: An epidemiological overview. Eur Resp J 2001; 18(Suppl 32): 2s-16s.
Thomeer MJ, Costabel U, Rizzato G, Poletti V, Demedts M. Comparison of registries of interstitial lung diseases in three European countries. Eur Respir J 2001; 18(Suppl 32): 114s-118s.
Gaensler EA, Carrington CB. Open lung biopsy for chronic diffuse infiltrative lung disease: Clinical, roentgenographic, and physiological correlations in 502 patients. Ann Thorac Surg 1980; 30: 411–426.
López-Campos Bodineau JL, Fernández Guerra J, Lara Blanquer A, et al. Analysis of admissions due to chronic obstructive pulmonary disease in Andalusia, year 2000. Arch Bronconeumol 2002; 38: 473–478.
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
López-Campos, J.L., Rodríguez-Becerra, E. & The Neumosur Task Group of the Registry of Interstitial Lung Diseases (RENIA). Incidence of interstitial lung diseases in the south of Spain 1998–2000: The RENIA study. Eur J Epidemiol 19, 155–161 (2004). https://doi.org/10.1023/B:EJEP.0000017660.18541.83
Issue Date:
DOI: https://doi.org/10.1023/B:EJEP.0000017660.18541.83